Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarEmerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Data solutions
Index solutions
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Filters (2)
More (2)
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Reset
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
Proclara BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$112.79MSeries F11/7/2018$6.92M$310.98M$0.90Undisclosed Investors
Rakuten MedicalHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$874.92MSeries F-31/7/2026$3.6M$636.9M$1.03Taiwania Capital, Axil Capital Group, Daiwa Securities, Mitsui Sumitomo Insurance Company, Sumitomo Mitsui Banking, ABIES Capital, Nexus CVC, OEP Group, SBI Group, Rakuten, Mickey Mikitani
Rénibus TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$148.41MSeries B7/17/2025$90M$238.38M$3.06Undisclosed Investors
Sail BiomedicinesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.95BSeries BB Prime10/19/2023$123.4M$2.62B$28.01Undisclosed Investors
Scorpion TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.02BSeries C-27/16/2024$24.31M$821.83M$2.54Frazier Life Sciences, Lightspeed Venture Partners, Willett Advisors, Omega Funds, Vida Ventures, Atlas Venture, Abingworth, Fidelity, Boxer Capital, EcoR1 Capital, Surveyor Capital, Invus, Wellington Management, Nextech Invest, OrbiMed, Logos Capital, Woodline Partners LP, Casdin Capital
Seismic TherapeuticHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$470.32MSeries B12/4/2023$146.28M$396.35M$4.52Bessemer Venture Partners, Amgen Ventures, Codon Capital, Alexandria Venture Investments, Gaingels, GC&H, Timothy A. Springer, Lightspeed Venture Partners, Polaris Partners, Boxer Capital, GV, Samsara BioCapital
Stemedica Cell TechnologiesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Superluminal MedicinesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$218.16MSeries B-19/3/2026$60M$600.4M$3.28BVF Partners, Deep Track Capital, Perceptive Advisors, RA Capital Management, Insight Partners, NVIDIA, Catalio Capital Management, Eli Lilly and Company, Cooley, Gaingels
Tesis BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
VilyaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
VisionGateHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
908 DevicesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
AcelyrinHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$558MSeries C9/9/2022$300M$809.52M$6.22Access Biotechnology, Matrix Capital Management, Westlake Village BioPartners, Cowen Healthcare Investments, Decheng Capital, Marshall Wace, OrbiMed, Samsara BioCapital, Surveyor Capital, Tybourne Capital Management, venBio Partners
Aera TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
AgNovos BioscienceHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$257.83MSeries B12/20/2023$44.85M$338.24M$35.76Undisclosed Investors
Alterome TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$231.07MSeries B4/3/2024$132M$356.19M$4.08Goldman Sachs Alternatives, Canaan Partners, Invus, Driehaus Capital Management, Digitalis Ventures, Blue Owl Capital, OrbiMed, Nextech Invest, Vida Ventures, Boxer Capital, Colt Ventures
Ansa BiotechnologiesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$57.42MSeries B Plus10/1/2025$24.28M$260.65M$0.35Cerberus Ventures, Blue Water Life Science Advisors, Altitude Life Science Ventures, Fall Line Capital, AIM13, Black Opal Ventures
Blackthorn TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Blue Earth DiagnosticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Candel TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Checkmate PharmaceuticalsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Cognito TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
CultureHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$142.12MSeries C-212/16/2025$20.52M$60.79M$0.29Northpond Ventures, Synthesis Capital, S32, Cultivian Sandbox
Dispatch BiotherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$179.79MSeries A7/23/2025$114M$270.29M$3.04ARCH Venture Partners, PICI, Bristol Myers Squibb, University of Pennsylvania, Stanford University, Alexandria Venture Investments
169-192 of 500

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.